Untech signs strategic partnership with Elea for Co-Development and Commercialization in Latin America

Untech announced a landmark strategic partnership with Elea, one of the leading pharmaceutical companies in Latin America, to co-develop and commercialize its innovative chronic wound therapy across the region. This agreement represents a major milestone in Untech’s trajectory, marking its transition toward market entry.

The partnership includes joint development of the final pharmaceutical formulation, regulatory strategy, and full commercialization throughout Latin America, with a royalty-based structure. By joining forces with a regional leader like Elea, Untech significantly accelerates its path to patients and reinforces the global potential of its breakthrough technology.